A Study to Evaluate the Safety and Clinical Outcome of Using FR-Mask in Breast Cancer Patients With Radiation-irritated Skin After Radiotherapy
NCT04190381 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2019-12-09
Summary
The breast radiotherapy after breast-conserving surgery reduces the risk of recurrence and death and is widely used for standard treatment for breast cancer. However, radiation dermatitis is a major adverse event of breast radiotherapy. Radiation-irritated skin is a treatment-induced symptom caused by radiation dose-limiting toxicity. It damages skin structure and causes a variety of symptoms of cuticle thinning, sweat glands damage, sebaceous glands damage and basal membrane damage. Radiation-irritated skin also leads to lost work productivity, wound care costs, social isolation and altered body image. Thus, radiation-irritated skin can greatly impact the quality of life.
Several studies have examined the effects of numerous topical agents to reduce the dryness of skin. However, the reported results have not been clinically significant. Previous studies have shown that deer antler velvet extract possess inflammatory function and repair damaged follicles, sweat glands and sebaceous gland. And biocellulose membrane is a highly efficient media to introduce velvet extract to damaged skin tissue.
In this study, velvet extract combined with biocellolose membrane will be used in breast cancer patients to test the safety and efficacy to alleviate their radiation-irritated skin symptoms.
The investigational medical product of this study is a biomedical repair mask, FR-MASK ;the formula of FR-Mask is deer antler velvet, which is a traditional Chinese tonic medicine combined with high-adhesion biocellulose membrane.
The primary objective of this study is to test the safety and clinical outcomes of FR-Mask application in breast cancer patients who have radiation-irritated skin due to the post-operative radiotherapy.
Conditions
Interventions
- OTHER
-
FR-Mask
The investigational medical product of this study is a biomedical repair mask, FR-MASK, acting like moisturizing lotion applied on breasts. The FR-Mask is applied to users' radiation-irritated breast skin for 15 to 20 minutes every 3 days.
Sponsors & Collaborators
-
China Medical University Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-06
- Primary Completion
- 2020-07-31
- Completion
- 2021-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
NCT07066280 ·Status: RECRUITING ·Phase: PHASE3
-
LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients
NCT04261387 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
NCT05032768 ·Status: RECRUITING
-
Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.
NCT04483856 ·Status: COMPLETED ·Phase: NA
-
Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients
NCT04320979 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Phase III Study of 5tx vs 15tx of RT (X-rays or Protons) Including RNI in Breast Cancer Patients
NCT04443413 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Patient Reported Outcomes Using Mepitel Film During Radiotherapy
NCT06133218 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer
NCT03856372 ·Status: RECRUITING ·Phase: NA
-
Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy
NCT03924011 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction
NCT07084519 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Radiation Care® Gel
NCT04995328 ·Status: COMPLETED ·Phase: NA
-
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
NCT01417286 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer
NCT00818051 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Radiotherapy on Patients Undergoing DIEP Flap Breast Reconstruction
NCT03072316 ·Status: UNKNOWN
-
RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast Cancer
NCT04069884 ·Status: RECRUITING ·Phase: NA
-
Postoperative Radiation of Patients With Breast Cancer in Extreme Hypofractionation.
NCT05452083 ·Status: NOT_YET_RECRUITING
-
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
NCT00793962 ·Status: COMPLETED ·Phase: PHASE3
-
Late-term Effects of Hypofractionated Chest Wall and Regional Nodal Irradiation in Patients With Breast Cancer
NCT04175821 ·Status: COMPLETED
-
Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer
NCT00005587 ·Status: COMPLETED ·Phase: PHASE3
-
Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant
NCT05213962 ·Status: ENROLLING_BY_INVITATION
-
Evaluating Mepitel in Post-mastectomy Patients and the Role of the Skin Microbiome in Radiation Dermatitis
NCT03519438 ·Status: COMPLETED
-
Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
NCT01544504 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer
NCT01245712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis
NCT02251392 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase II Study of Intra-Operative Electron Irradiation and External Beam Irradiation After Lumpectomy in Patients With T1N0M0 and T2N0M0 Breast Cancer
NCT01215162 ·Status: COMPLETED ·Phase: PHASE2